http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107029188-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-586 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107029188-B |
titleOfInvention | Traditional Chinese medicine compound for reducing recurrence rate of tumor patients |
abstract | A traditional Chinese medicine compound for reducing the recurrence rate of tumor patients relates to a traditional Chinese medicine compound. The composition comprises the following components in percentage by mass: 10-50 g of salvia miltiorrhiza, 10-50 g of curcuma zedoary, 3-20 g of radix pseudostellariae, 6-30 g of poria cocos, 3-30 g of pinellia ternate, 3-30 g of fritillaria ussuriensis, 3-50 g of oyster, 3-50 g of lapis chlorite, 3-15 g of elecampane, 3-30 g of fried rice sprout and 3-30 g of tuber fleeceflower stem. Animal experiments prove that the traditional Chinese medicine composition has the effects of obviously prolonging the survival period of the mice with cancer solid transplantable tumor and ascites tumor chemotherapy, antagonizing the reduction of leucocytes, promoting the apoptosis of cancer cells, inhibiting the pathological proliferation of tumor tissues and the like. The indications, all patients after the operation chemotherapy and patients after the simple chemotherapy achieve the purposes of prolonging the life cycle, improving the life quality and reducing the recurrence rate. Developing a Chinese food word-strengthening health product completely based on Chinese herbal medicines which can be used for health food; the Chinese patent medicine with more obvious effects of various formulations is developed in a long-term target way. |
priorityDate | 2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.